Streetbeat News

Partnerships

ALLR

Allarity Therapeutics has partnered with FivepHusion to support the clinical development of Deflexifol with DRP companion diagnostics. This collaboration has led to a rise in Allarity's share prices.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 12:32 pm

SCBFF

Standard Chartered PLC (OTC:SCBFF) has signed a pact with China's Ant Group to deepen their partnership in green and inclusive finance, global fund management, and sustainable development. The companies will address environmental issues of climate change and ocean protection. Standard Chartered will support Ant Group in building a global liquidity and foreign exchange management structure and strengthen its collaboration in ESG, digital innovation, and inclusive finance.

Portfolio Pulse from Nabaparna Bhattacharya

July 31, 2023 | 12:32 pm

AMEH

Apollo Medical Holdings (AMEH) has announced a partnership with IntraCare to advance value-based care in Texas and Oklahoma. The partnership aims to improve patient outcomes and reduce healthcare costs.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 12:24 pm

ORCL

Oracle has introduced a new Cloud Native Secure Cloud Computing Architecture (SCCA) Landing Zone solution for the U.S. Department of Defense. This solution aims to reduce barriers to cloud adoption and enables mission owners to rapidly build compliant architectures.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 12:16 pm

BIGC

GOOG

GOOGL

BigCommerce is set to launch new ecommerce features powered by Google Cloud AI. These tools will enhance the platform's capabilities, enabling enterprise merchants globally to work more efficiently, improve sales, boost conversions, and enhance customer experiences.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 12:10 pm

SPRO

Spero Therapeutics has announced a Special Protocol Assessment agreement with the FDA for the Phase 3 PIVOT-PO trial of Tebipenem HBr. This agreement will guide the design, execution, and analysis of the trial, potentially expediting the drug's approval process.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 12:07 pm

AYTU

Aytu BioPharma has signed an exclusive agreement with Medomie Pharma to commercialize its ADHD treatment tablets, Adzenys XR-ODT and Cotempla XR-ODT, in Israel and the Palestinian Authority. This is Aytu's first international commercial agreement for these products. Medomie will seek local regulatory approvals and marketing authorizations for both products.

Portfolio Pulse from Happy Mohamed

July 31, 2023 | 12:06 pm

AMRN

Amarin Corporation (AMRN) has entered into an exclusive partnership agreement with Lotus Pharmaceuticals to commercialize Vazkepa in Southeast Asia and South Korea. The deal is expected to expand Amarin's global footprint and increase its revenue potential.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 12:05 pm

LDOS

MSFT

Leidos and Microsoft have announced a collaboration to expedite the development of advanced cloud technology. The partnership aims to leverage Microsoft's Azure platform and Leidos' expertise in digital modernization to deliver innovative solutions.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 12:05 pm

TFFP

TFF Pharmaceuticals and Uniphar Durbin Ireland have opened an expanded access program for Voriconazole Inhalation Powder, a treatment for pulmonary aspergillosis and other voriconazole responsive fungal pulmonary infections.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2023 | 11:10 am